ArticleScientific reports2026
The associations of maternal liver biomarkers in different trimesters with birth weight outcomes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
We aimed to examine the association of maternal liver biomarkers in different trimesters and their changes with outcomes of neonatal birth weight. This prospective pregnant cohort study included pregnant women with the first prenatal follow-up record, the birth registration record and at least one record of liver function tests during pregnancy at Zhoushan Maternal and Child Care Hospital. Liver enzymes were routinely measured at the first (T1), second (T2) and third trimester (T3). Our study included 12,728 mother-infant pairs, of which 1,003 (7.89%) developed low birth weight (LBW)/small for gestational age (SGA) and 1,047 (8.23%) developed macrosomia/large for gestational age (LGA), respectively. The highest quartile of maternal ALT, AST, and GGT at T2, as well as the change of GGT during pregnancy were significantly associated with a higher risk of LBW/SGA. In addition, pregnant women with higher levels of ALP and AST/ALT at T3 had an increased risk of delivering infants with macrosomia/LGA, and higher early pregnancy levels and greater increases in AST/ALT were also related to an increased risk of macrosomia/LGA. Elevated levels of liver biomarkers are associated with adverse birth weight outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.